[{"NetIncomeLoss_1_Q1_USD":-61000000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-102000000.0,"PaymentsForRestructuring_1_Q1_USD":38000000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":10000000.0,"InventoryRawMaterialsAndSupplies_0_Q1_USD":211000000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":18000000.0,"ProceedsFromIssuanceOfSeniorLongTermDebt_1_Q1_USD":0.0,"ValuationAllowanceDeferredTaxAssetChangeInAmount_1_Q1_USD":2000000.0,"PaymentsForProceedsFromOtherInvestingActivities_1_Q1_USD":7000000.0,"AssetsCurrent_0_Q1_USD":3344000000.0,"LongTermDebt_0_Q1_USD":6161000000.0,"RestructuringSettlementAndImpairmentProvisions_1_Q1_USD":108000000.0,"LongTermDebtCurrent_0_Q1_USD":605000000.0,"ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_1_Q1_USD":-7000000.0,"RestructuringCharges_1_Q1_USD":39000000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":348000000.0,"ContractWithCustomerLiability_0_Q1_USD":251000000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":569000000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":1600000.0,"GainLossOnSaleOfOtherAssets_1_Q1_USD":0.0,"CommonStockSharesIssued_0_Q1_shares":472968567.0,"PaymentsForSoftware_1_Q1_USD":5000000.0,"Assets_0_Q1_USD":16988000000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":-405000000.0,"ShareBasedCompensation_1_Q1_USD":15000000.0,"PaymentsToAcquireBusinessesNetOfCashAcquired_1_Q1_USD":-73000000.0,"InventoryFinishedGoods_0_Q1_USD":613000000.0,"DeferredFinanceCostsNet_0_Q1_USD":93000000.0,"IncreaseDecreaseInOperatingCapital_1_Q1_USD":183000000.0,"CommitmentsAndContingencies_0_Q1_USD":0.0,"EarningsPerShareBasic_1_Q1_USD":-0.12,"RepaymentsOfLongTermLinesOfCredit_1_Q1_USD":20000000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":-25000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":486700000.0,"DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_1_Q1_USD":2000000.0,"InventoryLIFOReserve_0_Q1_USD":30000000.0,"AccountsReceivableNetCurrent_0_Q1_USD":1028000000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":-19000000.0,"CommonStockValue_0_Q1_USD":0.0,"ProceedsFromIssuanceOrSaleOfEquity_1_Q1_USD":0.0,"ProceedsFromLinesOfCredit_1_Q1_USD":50000000.0,"OtherReceivablesNetCurrent_0_Q1_USD":104000000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":202000000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q1_pure":0.235,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":2000000.0,"BusinessCombinationIntegrationRelatedCosts_1_Q1_USD":81000000.0,"CostsAndExpenses_1_Q1_USD":1322000000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-466000000.0,"AmortizationOfIntangibleAssets_1_Q1_USD":147000000.0,"OtherAssetsNoncurrent_0_Q1_USD":325000000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":515000000.0,"Liabilities_0_Q1_USD":8981000000.0,"InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_0_Q1_USD":-28000000.0,"EquityMethodInvestments_0_Q1_USD":34000000.0,"InventoryGross_0_Q1_USD":1454000000.0,"RestrictedCashCurrent_0_Q1_USD":0.0,"ResearchAndDevelopmentExpense_1_Q1_USD":89000000.0,"BusinessExitCosts1_1_Q1_USD":0.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":1242000000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q1_USD":-466000000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":22000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":486700000.0,"InventoryWorkInProcess_0_Q1_USD":630000000.0,"GainLossOnDispositionOfAssets_1_Q1_USD":0.0,"LiabilitiesCurrent_0_Q1_USD":2034000000.0,"AccountsPayableCurrent_0_Q1_USD":411000000.0,"PaymentsOfDebtIssuanceCosts_1_Q1_USD":0.0,"RestructuringReserveAccrualAdjustment1_1_Q1_USD":-13000000.0,"NonoperatingIncomeExpense_1_Q1_USD":0.0,"InterestExpense_1_Q1_USD":61000000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":515000000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":273000000.0,"SeveranceCosts1_1_Q1_USD":26000000.0,"LongTermDebtNoncurrent_0_Q1_USD":5556000000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":6032000000.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_1_Q1_shares":0.0,"AdditionalPaidInCapital_0_Q1_USD":8647000000.0,"PaymentsToAcquireIntangibleAssets_1_Q1_USD":33000000.0,"NumberOfOperatingSegments_1_Q1_segment":1.0,"DeferredIncomeTaxLiabilitiesNet_0_Q1_USD":828000000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_1_Q1_USD":0.0,"ProceedsFromPaymentsForOtherFinancingActivities_1_Q1_USD":-17000000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":1271000000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":15000000.0,"CommonStockSharesAuthorized_0_Q1_shares":5000000000.0,"ImpairmentOfLongLivedAssetsToBeDisposedOf_1_Q1_USD":9000000.0,"Goodwill_0_Q1_USD":6016000000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_1_Q1_USD":53000000.0,"InventoryNet_0_Q1_USD":1424000000.0,"RestructuringReserve_0_Q1_USD":118000000.0,"OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_1_Q1_USD":-8000000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":331000000.0,"PreferredStockValue_0_Q1_USD":0.0,"DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_1_Q1_USD":10000000.0,"DeferredIncomeTaxExpenseBenefit_1_Q1_USD":-32000000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":16988000000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":114000000.0,"PreferredStockSharesAuthorized_0_Q1_shares":1000000000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":247000000.0,"OtherLiabilitiesCurrent_0_Q1_USD":573000000.0,"StockholdersEquity_0_Q1_USD":8007000000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":18000000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q1_USD":9000000.0,"ProceedsFromHedgeInvestingActivities_1_Q1_USD":0.0,"PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_0_Q1_USD":316000000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-538000000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":9000000.0,"CommonStockSharesOutstanding_0_Q1_shares":472968567.0,"EarningsPerShareDiluted_1_Q1_USD":-0.12,"ContractWithCustomerLiabilityRevenueRecognized_1_Q1_USD":142000000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":1060000000.0,"OtherOperatingActivitiesCashFlowStatement_1_Q1_USD":10000000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-80000000.0,"LitigationReserve_0_Q1_USD":0.0,"Ticker":"ELAN","CIK":"1739104","name":"ELANCO ANIMAL HEALTH INC","OfficialName":"Elanco Animal Health Incorporated Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"12367077748.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20210507"}]